Capacity to utilize raffinose dictates pneumococcal disease phenotype V Minhas, RM Harvey, LJ McAllister, T Seemann, AE Syme, SL Baines, ... MBio 10 (1), 2019 | 14 | 2019 |
Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine SC David, Z Laan, V Minhas, AY Chen, J Davies, TR Hirst, SR McColl, ... Immunology and cell biology 97 (8), 726-739, 2019 | 8 | 2019 |
In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential tissue tropism of Streptococcus pneumoniae V Minhas, R Aprianto, LJ McAllister, H Wang, SC David, KT McLean, ... Communications biology 3 (1), 1-12, 2020 | 7* | 2020 |
Site-Specific Mutations of GalR Affect Galactose Metabolism in Streptococcus pneumoniae KT McLean, A Tikhomirova, EB Brazel, S Legendre, G Haasbroek, ... Journal of Bacteriology 203 (1), 2020 | 1 | 2020 |
Sickly Sweet–How Sugar Utilization Impacts Pneumococcal Disease Progression V Minhas, JC Paton, C Trappetti Trends in Microbiology, 2021 | | 2021 |
Host-glycan metabolism is regulated by a species-conserved two-component system in Streptococcus pneumoniae PR Andreassen, C Trappetti, V Minhas, FD Nielsen, K Pakula, JC Paton, ... PLoS pathogens 16 (3), e1008332, 2020 | | 2020 |
Pathogenesis of Streptococcus pneumoniae-a molecular characterisation V Minhas | | 2020 |
Text S1 PR Andreassen, C Trappetti, V Minhas, F Damgaard, KP Nielsen, ... | | |